ATYR - aTYR PHARMA INC

QQQ $ 602.61 $ 4.22 (0.71 %)

DIA $ 463.04 $ 0.00 (0 %)

SPY $ 665.11 $ 2.94 (0.44 %)

TLT $ 90.76 $ -0.20 (-0.22 %)

GLD $ 387.41 $ 6.60 (1.73 %)

Previous Close

$ 1.02

Open

$ 1.04

Bid

$ 0.99 x 1

Ask

$ 1.04 x 300

Day's Range

$ 1.00 - $ 1.08

52 Week Range

$ 0.68 - $ 7.29

Volume

5,496,346

Average Volume

Market Cap

99.95M

Beta (5Y Monthly)

$ 1.06

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-07-2025	03-31-2025	10-Q
3	03-13-2025	12-31-2024	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-13-2024	06-30-2024	10-Q
6	05-02-2024	03-31-2024	10-Q
7	03-14-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-09-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	03-14-2023	12-31-2022	10-K
12	11-14-2022	09-30-2022	10-Q
13	08-15-2022	06-30-2022	10-Q
14	05-10-2022	03-31-2022	10-Q
15	03-15-2022	12-31-2021	10-K
16	11-12-2021	09-30-2021	10-Q
17	08-11-2021	06-30-2021	10-Q
18	05-14-2021	03-31-2021	10-Q
19	03-24-2021	12-31-2020	10-K
20	11-13-2020	09-30-2020	10-Q
21	08-13-2020	06-30-2020	10-Q
22	05-12-2020	03-31-2020	10-Q
23	03-26-2020	12-31-2019	10-K
24	11-14-2019	09-30-2019	10-Q
25	08-14-2019	06-30-2019	10-Q
26	05-14-2019	03-31-2019	10-Q
27	03-26-2019	12-31-2018	10-K
28	11-14-2018	09-30-2018	10-Q
29	08-14-2018	06-30-2018	10-Q
30	05-15-2018	03-31-2018	10-Q
31	03-20-2018	12-31-2017	10-K
32	11-14-2017	09-30-2017	10-Q
33	08-14-2017	06-30-2017	10-Q
34	05-11-2017	03-31-2017	10-Q
35	03-16-2017	12-31-2016	10-K
36	11-14-2016	09-30-2016	10-Q
37	08-10-2016	06-30-2016	10-Q
38	05-11-2016	03-31-2016	10-Q
39	03-30-2016	12-31-2015	10-K
40	11-10-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

aTyr Pharma Highlights Trial Results For E...
09/30/2025 09:32:00

aTyr Pharma, Inc. (NASDAQ:ATYR) ("aTyr" or the "Company"), a clinical stage biotechnology company engaged in th...

benzinga-bulls-and-bears-intel-fedex-cracker-barrel--and-markets-close-at-record-highs

Benzinga Bulls And Bears: Intel, FedEx, Cr...
09/20/2025 12:01:14

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...

top-3-health-care-stocks-that-may-explode-in-september

Top 3 Health Care Stocks That May Explode ...
09/19/2025 11:01:11

goldman-sachs-to-rally-around-9-here-are-10-top-analyst-forecasts-for-tuesday

Goldman Sachs To Rally around 9%? Here Are...
09/16/2025 14:18:33

Wells Fargo Downgrades aTyr Pharma to Equa...
09/16/2025 13:14:52

Wells Fargo analyst Derek Archila downgrades aTyr Pharma (NASDAQ:ATYR) from Overweight to Equal-Weight and lowers the price ...

RBC Capital Downgrades aTyr Pharma to Sect...
09/16/2025 13:12:18

RBC Capital analyst Brian Abrahams downgrades aTyr Pharma (NASDAQ:ATYR) from Outperform to Sector Perform and lowers the pri...

crude-oil-rises-1-manufacturing-activity-in-new-york-falls-in-september

Crude Oil Rises 1%; Manufacturing Activity...
09/15/2025 18:57:49

HC Wainwright & Co. Downgrades aTyr Pharma...
09/15/2025 18:36:11

HC Wainwright & Co. analyst Joseph Pantginis downgrades aTyr Pharma (NASDAQ:ATYR) from Buy to Neutral.

12 Health Care Stocks Moving In Monday's I...
09/15/2025 17:06:06

atyr-pharma-stock-sinks-plans-fda-review-after-mixed-phase-3-results

ATyr Pharma Stock Sinks, Plans FDA Review ...
09/15/2025 15:24:18

ATyr Pharma's stock dips after Phase 3 trial of efzofitimod misses steroid reduction goal, but shows improvements in lung f...

nasdaq-gains-over-100-points-tesla-shares-spike-higher

Nasdaq Gains Over 100 Points; Tesla Shares...
09/15/2025 14:07:52

new-mountain-finance-texas-instruments-analog-devices-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

New Mountain Finance, Texas Instruments, A...
09/15/2025 12:05:09

Trading Halt: Halt status updated at 7:45:...
09/15/2025 11:45:04

aTyr Pharma Announced Topline Results From...
09/15/2025 11:32:50

Study did not meet primary endpoint in change from baseline in mean daily oral corticosteroid (OCS) dose at week 48, although c...

Trading Halt: Halted at 7:25:00 a.m. ET - ...
09/15/2025 11:25:04

why-check-cap-shares-are-trading-higher-by-183-here-are-20-stocks-moving-premarket

Why Check-Cap Shares Are Trading Higher By...
09/15/2025 09:45:57

nvidia-to-rally-more-than-22-here-are-10-top-analyst-forecasts-for-friday

Nvidia To Rally More Than 22%? Here Are 10...
08/22/2025 19:41:57

Jefferies Maintains Buy on aTyr Pharma, Ra...
08/22/2025 17:40:33

Jefferies analyst Roger Song maintains aTyr Pharma (NASDAQ:ATYR) with a Buy and raises the price target from $9 to $17.

ATyr Pharma Inc Files For Mixed Shelf Of U...
08/07/2025 21:25:26

– SEC Filing

aTyr Pharma Q2 EPS $(0.22) Misses $(0.17) ...
08/07/2025 20:09:37

aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.17)...